Eva Temkin, Jessica Greenbaum to Speak at Compliance Congress for Specialty Products

Washington, D.C. FDA and Life Sciences partner Eva Temkin and counsel Jessica Greenbaum will speak at Compliance Congress for Specialty Products in Boston on Sept. 21 on “Navigating the Intricacies of Specialty Cross Combination Products, Compliance Congress for Specialty Products.” As the specialty pharmaceutical and medical device industries continue to integrate, there has been an increase of cross combination products.  Eva and Jessica will discuss the challenges associated with the crossing of these industries, explore the different types of cross combination products, including devices that are literally administered or used, and understand the importance of drug companies being knowledgeable about their products, and learn how to think about risks in terms of these products.